Abstract
The gastrointestinal absorption characteristics of pafenolol following oral administration as a solution in man and rat has previously been found to be a double-peak phenomenon and exhibited dose-dependent bioavailability, despite negligible presystemic metabolism. In both man and rat the first peak appeared approximately 0.5–1 hr postdose and the second, more pronounced peak 3–4 hr postdose. In rat more than 90% of the available dose was absorbed during the second peak. In the present study we investigated the absorption of a solution of pafenolol in rats after intrajejunal and intraileal administration. The resulting blood concentration–time profile of pafenolol exhibited one peak only; the extent of absorption was similar to that observed when the same dose was given orally. The small intestinal transit time of the 14C-PEG 4000 solution was found to be more than 3 hr. The transit rate was higher in the proximal part of the small intestine compared to the more distal part, where the transit of the solution was staggered. In conclusion, the results of the intestinal transit time investigation and the administrations of pafenolol at different levels of the alimentary tract indicate that pafenolol is a drug with a specific absorption site located in the ileocolonic region.
Similar content being viewed by others
REFERENCES
J.-A. Björkman, L. Ek, E. Carlsson, and B. Lundgren. Pafenolol II. Cardiovascular effects in anaesthetized dogs. XVII Joint Meeting of the Scandinavian Physiological and Pharmacological Society, Reykjavik, August 1982. Acta Physiol. Scand. Suppl. 508:42 (1982) (abstr.).
B. Lundgren, E. Carlsson, and L. Ek. β-Blocking potency and selectivity in in vivo and in vitro experiments. XVII Joint Meeting of the Scandinavian Physiological and Pharmacological Society, Reykjavik, August 1982. Acta Physiol. Scand. Suppl. 508:44 (1982) (abstr.).
C. G. Regårdh, A, Heggelund, K. Kylberg-Hansen, and P. Lundborg. Pharmacokinetics of pafenolol after iv and oral administration of three separate doses of different strength to man. Biopharm. Drug Disp. 11:607–618 (1990).
C. G. Regårdh, P. Lundborg, M. Gabrielsson, A. Heggelund, and K. Kylberg-Hansen. Pharmacokinetics of a single intravenous and oral dose of pafenolol—a beta1-adrenoceptor antagonist with atypical absorption and disposition properties—in man. Pharm. Res. 7:1222–1227 (1990).
H. Lennernäs and C. G. Regårdh. Pharmacokinetics of pafenolol in the rat: A suitable model for studying absorption mechanisms of a drug exhibiting unusual absorption properties in man. Biopharm. Drug Disp. 11:619–631 (1990).
H. Lennernäs and C. G. Regårdh. Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat. Pharm. Res. (in press) (1993).
H. Lennernäs, L. Renberg, K.-J. Hoffman, and C. G. Regårdh. Investigation of the pharmacokinetics and metabolism of the β-blocker pafenolol in urine from rat and identification of the main metabolite in man. Prog. Metabol. Disp. (in press) (1993).
P.-O. Lagerström and B.-A. Persson. Method for pafenolol in dog plasma. Hässle Report No. BA-043 (1979).
Statistical Consultants, Inc. PCNONLIN and NONLIN: Software for the statistical analysis of nonlinear models. Am. Stat. 40:52 (1986).
K. Iga, Y. Ogama, T. Yashiki, and T. Shimamoto. Estimation of drug absorption rates using a deconvolution method with non-equal sampling times. J. Pharmacokin. Biopharm. 14:213–225 (1986).
S. S. Davis, J. G. Hardy, and J. W. Fara. Transit of pharmaceutical dosage forms through the small intestine. Gut 27:886–892 (1986).
A. Heggelund, C. Jansson, P. Lundborg, and C. G. Regårdh. The effect of food on the gastrointestinal absorption of pafenolol—a preliminary study. Hässle Report No. 206-778 (1982), pp. 1–10.
R. L. Oberle and G. L. Amidon. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; An explanation for the double peak phenomenon. J. Pharmacokin. Biopharm. 15:529–544 (1987).
D. R. C. Robertson, A. G. Renwick, N. D. Wood, N. Cross, B. S. Macklin, J. S. Fleming, D. G. Waller, and C. F. George. The influence of levodopa on gastric emptying in man. Br. J. Clin. Pharmacol. 29:47–53 (1990).
B. E. Dahlström and L. K. Paalzow. Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J. Pharmacokin. Biopharm. 6:505–519 (1978).
R. F. Bergström, D. R. Kay, T. M. Harkcom, and J. G. Wagner. Penicillamine kinetics in normal subjects. Clin. Pharmacol. Ther. 30:404–413 (1981).
Y. Plusquelle, G. Campistron, S. Staveris, J. Barre, L. Jung, J. P. Tillement, and G. Houin. A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: A double-site model for drug absorption. J. Pharmacokin. Biopharm. 15:225–239 (1987).
C. S. Marcus and F. W. Lengemann. Use of radioyttrium to study food movements in the small intestine of the rat. J. Nutr. 76:179–182 (1962).
F. Nilsson. Small bowel propulsive motility in the rat. Acta Chir. Scand. 138:830–833 (1972).
G. Petterson, H. Ahlman, and J. Kewenter. A comparison of small intestinal transit time between the rat and the guinea-pig. Acta Chir. Scand. 142:537–540 (1976).
H. Yuasa, T. Iga, M. Hanano, and J. Watanabe. Relationship between the first-order intestinal absorption rate constant in vivo and the membrane permeability clearance in a perfusion system: An intragastric administration method in vivo. J. Pharmacobio-Dyn. 12:264–271 (1989).
H. W. Smith. Observations of the flora of the alimentary tract of animals and factors affecting its composition. J. Pathol. Bacteriol. 89:95–115 (1965).
A. McIntyre, G. P. Young, T. Taranto, P. R. Gibson, and P. B. Ward. Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology 101:1274–1281 (1991).
K. Turnheim and F. Lauterbach. Interaction between intestinal absorption and secretion of monoquarternary ammonium compounds in guinea pigs—a concept for the absorption kinetics of organic cations. J. Pharmacol. Exp. Ther. 212:418–424 (1980).
T. Yamaguchi, C. Ikeda, and Y. Sekine. Intestinal absorption of a β-adrenergic blocking agent nadolol. I. Comparison of absorption behavior of nadolol with those of other β-blocking agents in rats. Chem. Pharm. Bull. 34:3362–3369 (1986).
T. Yamaguchi, C. Ikeda, and Y. Sekine. Intestinal absorption of a β-adrenergic blocking agent nadolol. II. Mechanism of the inhibitory effect on the intestinal absorption of nadolol by sodium cholate in rats. Chem. Pharm. Bull. 34:3836–3843 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lennernäs, H., Regårdh, CG. Regional Gastrointestinal Absorption of the Beta-Blocker Pafenolol in the Rat and Intestinal Transit Rate Determined by Movement of 14C-Polyethylene Glycol (PEG) 4000. Pharm Res 10, 130–135 (1993). https://doi.org/10.1023/A:1018993501426
Issue Date:
DOI: https://doi.org/10.1023/A:1018993501426